Literature DB >> 30783468

miR-34a alleviates spinal cord injury via TLR4 signaling by inhibiting HMGB-1.

Jianmin Zhou1, Ou Shuang1, Jian Li1, Zijun Cai1, Chong Wu1, Wenyu Wang1.   

Abstract

The aim of the present study was to investigate the effect of microRNA (miR)-34a on spinal cord injury (SCI)-induced inflammation and the possible underlying mechanisms. The results indicated that miR-34a expression was downregulated in a rat model of SCI compared with the control group. Furthermore, miR-34a knockdown was demonstrated to aggravate inflammation, inhibit cell proliferation and enhance apoptosis in an in vitro model of SCI. MiR-34a inhibition was demonstrated to upregulate the expression of inducible nitric oxide synthase and nitric oxide, as well as inducing the expression of toll-like receptor 4 (TLR4) and high mobility group box-1 (HMGB-1) in an in vitro model of SCI. TLR4 inhibitor reduced the effects of miR-34a downregulation on inflammation and cell growth in SCI. Together, these results suggest that miR-34a is able to alleviate SCI via inhibiting HMGB-1 expression in TLR4 signaling.

Entities:  

Keywords:  high mobility group box 1; inflammation; microRNA-34a; spinal cord injury; toll-like receptor 4

Year:  2018        PMID: 30783468      PMCID: PMC6364175          DOI: 10.3892/etm.2018.7102

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  7 in total

Review 1.  High-Mobility Group Box 1 in Spinal Cord Injury and Its Potential Role in Brain Functional Remodeling After Spinal Cord Injury.

Authors:  Zhiwu Wu; Meihua Li
Journal:  Cell Mol Neurobiol       Date:  2022-06-17       Impact factor: 5.046

2.  CircRNA3616 knockdown attenuates inflammation and apoptosis in spinal cord injury by inhibiting TLR4/NF-κB activity via sponging miR-137.

Authors:  Li Wang; Zhiwen Song; Hongjun Zou; Haining Chen; Yong Hu; Xiangnan Li; Jinbo Liu
Journal:  Mol Cell Biochem       Date:  2022-08-01       Impact factor: 3.842

3.  MicroRNA-182 improves spinal cord injury in mice by modulating apoptosis and the inflammatory response via IKKβ/NF-κB.

Authors:  Min Fei; Zheng Li; Yuanwu Cao; Chang Jiang; Haodong Lin; Zixian Chen
Journal:  Lab Invest       Date:  2021-05-31       Impact factor: 5.662

4.  Therapeutic effects and long-term outcomes of HMGB1-targeted therapy in rats and mice with traumatic spinal cord injury: A systematic review and meta-analysis.

Authors:  Chen Deng; Li Deng; Junqiao Lv; Lin Sun
Journal:  Front Neurosci       Date:  2022-09-07       Impact factor: 5.152

5.  MicroRNAs Promote the Progression of Sepsis-Induced Cardiomyopathy and Neurovascular Dysfunction Through Upregulation of NF-kappaB Signaling Pathway-Associated HDAC7/ACTN4.

Authors:  Qiancheng Luo; Hanning Ma; Enwei Guo; Lin Yu; Ling Jia; Bingyu Zhang; Gang Feng; Rui Liu
Journal:  Front Neurol       Date:  2022-06-09       Impact factor: 4.086

6.  Gypenoside XVII protects against spinal cord injury in mice by regulating the microRNA‑21‑mediated PTEN/AKT/mTOR pathway.

Authors:  Tianyu Sun; Liying Duan; Jiaju Li; Hongyu Guo; Mingyue Xiong
Journal:  Int J Mol Med       Date:  2021-06-16       Impact factor: 4.101

7.  MicroRNA-34a deficiency leads to impaired wound closure by augmented inflammation in mice.

Authors:  Na Zhao; Guojian Wang; Shuang Long; Mengjia Hu; Jining Gao; Xinze Ran; Junping Wang; Yongping Su; Tao Wang
Journal:  Ann Transl Med       Date:  2020-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.